Ningbo No.2 Hospital
Clinical trials sponsored by Ningbo No.2 Hospital, explained in plain language.
-
New combo therapy aims to stop liver cancer return in hepatitis b patients
Disease control Not yet recruitingThis early-phase study looks at whether adding peginterferon alfa-2β to standard antiviral drugs can improve outcomes for people with hepatitis B-related liver cancer after their tumor is surgically removed. About 156 adults aged 18 to 65 will receive either the combination or an…
Phase: EARLY_PHASE1 • Sponsor: Ningbo No.2 Hospital • Aim: Disease control
Last updated May 17, 2026 13:09 UTC
-
Heart pacing showdown: which lead works best for a better beat?
Disease control Not yet recruitingThis study tests two different pacing leads (lumenless vs. stylet-driven) for a newer heart pacing technique called left bundle branch pacing. The goal is to see which lead is safer and more effective at placing the pacing wire correctly during the procedure. About 288 people wit…
Phase: NA • Sponsor: Ningbo No.2 Hospital • Aim: Disease control
Last updated May 13, 2026 16:03 UTC